雜志介紹

Purinergic Signalling雜志介紹

《Purinergic Signalling》是一(yi)本以English為主(zhu)的(de)(de)未開放(fang)獲取國際優(you)秀期(qi)刊(kan)，中文名稱嘌呤能信號，本刊(kan)主(zhu)要出(chu)版、報(bao)道醫學(xue)-NEUROSCIENCES領(ling)(ling)(ling)域的(de)(de)研(yan)究動態(tai)以及在該(gai)領(ling)(ling)(ling)域取得的(de)(de)各方面的(de)(de)經(jing)驗和科(ke)研(yan)成果(guo)，介紹該(gai)領(ling)(ling)(ling)域有(you)關本專業的(de)(de)最新(xin)(xin)進展，探(tan)討行業發(fa)展的(de)(de)思路和方法，以促進學(xue)術信息交流(liu)，提高行業發(fa)展。該(gai)刊(kan)已被(bei)國際權威數(shu)據庫SCIE收錄(lu)，為該(gai)領(ling)(ling)(ling)域相關學(xue)科(ke)的(de)(de)發(fa)展起到了(le)良(liang)好的(de)(de)推動作用，也得到了(le)本專業人員的(de)(de)廣(guang)泛認可。該(gai)刊(kan)最新(xin)(xin)影(ying)響因子為3，最新(xin)(xin)CiteScore 指數(shu)為6.6。

本刊近期中國學者發表的(de)論文主要有：

• Purinergic signaling: a potential therapeutic target for depression and chronic pain

  Author: Zou, Yuting; Yang, Runan; Li, Lin; Xu, Xiumei; Liang, Shangdong

• Purinergic ATP triggers moxibustion-induced local anti-nociceptive effect on inflammatory pain model

  Author: Yin, Hai-Yan; Fan, Ya-Peng; Liu, Juan; Li, Dao-Tong; Guo, Jing; Yu, Shu-Guang

• In silico identification of A1 agonists and A2a inhibitors in pain based on molecular docking strategies and dynamics simulations

  Author: Xu, Guangya; Zhang, Shutao; Zheng, Lulu; Hu, Zhongjiao; Cheng, Lijia; Chen, Lvlin; Li, Jun; Shi, Zheng

• Inhibition of phosphorylated calcium/calmodulin-dependent protein kinase II alpha relieves streptozotocin-induced diabetic neuropathic pain through regulation of P2X3 receptor in dorsal root ganglia

  Author: He, Xiao-fen; Kang, Yu-rong; Fei, Xue-yu; Chen, Lu-hang; Li, Xiang; Ma, Yi-qi; Hu, Qun-qi; Qu, Si-ying; Wang, Han-zhi; Shao, Xiao-mei; Liu, Bo-yi; Yi-Liang; Du, Jun-ying; Fang, Jian-qiao; Jiang, Yong-liang

英文介紹

Purinergic Signalling雜志英文介紹

Nucleotides and nucleosides are primitive biological molecules that were utilized early in evolution both as intracellular energy sources and as extracellular signalling molecules. ATP was first identified as a neurotransmitter and later as a co-transmitter with all the established neurotransmitters in both peripheral and central nervous systems. Four subtypes of P1 (adenosine) receptors, 7 subtypes of P2X ion channel receptors and 8 subtypes of P2Y G protein-coupled receptors have currently been identified. Since P2 receptors were first cloned in the early 1990’s, there is clear evidence for the widespread distribution of both P1 and P2 receptor subtypes in neuronal and non-neuronal cells, including glial, immune, bone, muscle, endothelial, epithelial and endocrine cells.